Author:
Belinschi Vadim,Iheagwara Charity,Muhanna Ala
Publisher
Springer Science and Business Media LLC
Reference10 articles.
1. WHO. Guidelines for diagnosing, preventing and managing cryptococcal disease among adults, adolescents and children living with HIV. (2022). Accessed: January 14, 2024: https://www.who.int/publications/i/item/9789240052178.
2. Cryptococcal meningitis: diagnosis and management update;Abassi M;Curr Trop Med Rep,2015
3. The acceptability of the AMBITION-cm treatment regimen for HIV-associated cryptococcal meningitis: findings from a qualitative methods study of participants and researchers in Botswana and Uganda;Lawrence DS;PLoS Negl Trop Dis,2022
4. AMBITION-cm: intermittent high dose AmBisome on a high dose fluconazole backbone for cryptococcal meningitis induction therapy in sub-Saharan Africa: study protocol for a randomized controlled trial;Molefi M;Trials,2015
5. DermNet. Morbilliform drug reaction (maculopapular drug eruption). (2009). Accessed: November 3, 2023: https://dermnetnz.org/topics/morbilliform-drug-reaction.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献